Comparison of Claudin‐4, BerEP4 , Carcinoembryonic Antigen and MOC31 in Serous Fluids Metastases Demonstrate High Sensitivity of Claudin‐4 at Low Cellularity
Diagnostic Cytopathology · 2024
DOI: 10.1002/dc.25393 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Diagnostic Cytopathology, 2024. Verfasst von Joshua J X Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Queen Mary Hospital, School of Clinical Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong. Hauptthemen laut MEDLINE: Claudin-4, Biomarkers, Tumor, Carcinoembryonic Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Claudin‐4 has been described as a highly sensitive immunocytochemical marker for detection of metastatic carcinoma cells in effusion cytology specimens. This study aims to challenge the performance of claudin‐4 in different types of malignancies and low cellularity specimens, by comparison with other markers in a large cohort of carcinomatous effusion specimens. Methodology Cell block preparations from peritoneal and pleural fluid specimens were retrieved, with malignant (carcinoma) diagnoses confirmed by review of hospital diagnosis code and pathology reports. Claudin‐4, BerEP4, CEA, and MOC31 immunocytochemistry were performed and scored by expression proportion and intensity. Tumor cellularity was assessed for subgroup analysis of low cellularity specimens.
Results
Totally 147 specimens (70 pleural, 77 peritoneal) of 68 lung, 62 breast, 9 gynecological, and 7 gastrointestinal carcinomas were retrieved. The average proportion expression of claudin‐4 was highest (89.6%, vs. CEA 40.5%, BerEp4 18.6%, MOC31 16.8%) and the percentage of strong expression was highest for claudin‐4 (72.1%). Expression levels of claudin‐4 were consistently higher than other markers in subgroups of all primary sites. The difference was more significant for low cellularity specimens. High (≥50%) proportion expression was seen for 96.61% of cases for claudin‐4 (vs. BerEp4 8.77%, CEA 46.55%, MOC31 8.77%, p < 0.001). These factors contributed to a low concordance between claudin‐4 and BerEp4, CEA and MOC31 ( K = 0.010–0.043).
Conclusion
Claudin‐4 is more sensitive than CEA, BerEp4 and MOC31, suitable for low cellularity specimens of most types of metastatic carcinoma and is a robust immunocytochemical marker for carcinoma that can be used solitarily.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Queen Mary Hospital, School of Clinical Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
- Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong.
- Department of Pathology, Alice Ho Miu Ling Nethersole Hospital, Sheung Shui, New Territories, Hong Kong.
- Department of Pathology, North District Hospital, Sheung Shui, New Territories, Hong Kong.
Zitieren
APA
Li, J. J. X., Ng, J. K. M., Tsang, J. Y., Tsang, Y. T., Mak, K. F., & Tse, G. M. (2024). Comparison of Claudin‐4, BerEP4 , Carcinoembryonic Antigen and MOC31 in Serous Fluids Metastases Demonstrate High Sensitivity of Claudin‐4 at Low Cellularity. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25393
Vancouver
Li JJX, Ng JKM, Tsang JY, Tsang YT, Mak KF, Tse GM. Comparison of Claudin‐4, BerEP4 , Carcinoembryonic Antigen and MOC31 in Serous Fluids Metastases Demonstrate High Sensitivity of Claudin‐4 at Low Cellularity. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25393
BibTeX
@article{Li2024,
author = {Li, Joshua J X and Ng, Joanna K M and Tsang, Julia Y and Tsang, Yuen Ting and Mak, Ko Fung and Tse, Gary M},
title = {Comparison of Claudin‐4, BerEP4 , Carcinoembryonic Antigen and MOC31 in Serous Fluids Metastases Demonstrate High Sensitivity of Claudin‐4 at Low Cellularity},
journal = {Diagnostic Cytopathology},
year = {2024},
doi = {10.1002/dc.25393}
}
EUVIMED